Develops and sells medical devices and therapies for heart and blood-vessel conditions, neurological and spinal disorders, and surgical care to healthcare systems, clinicians, and patients.
10-K for FY2026, filed Jun 18, 2026We have three reportable segments that primarily develop, manufacture, distribute, and sell device-based medical therapies and services…View ↗
The Cardiovascular Portfolio is made up of the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic, and Coronary & Peripheral…View ↗
NEUROSCIENCE PORTFOLIOView ↗
The Medical Surgical Portfolio includes the Surgical & Endoscopy and Acute Care & Monitoring divisions. Products and therapies of this…View ↗
Sells through its own sales representatives and independent distributors. Hospitals, clinics, physician offices, and other care providers use its products; group purchasing organizations and health networks negotiate supply contracts for member facilities.
10-K for FY2026, filed Jun 18, 2026We sell our medical devices and therapies through a combination of direct sales representatives and third parties (e.g., independent…View ↗
Our marketing and sales strategy is focused on rapid, cost-effective delivery of high-quality products to a diverse group of customers…View ↗
The Company's revenues are principally derived from device-based medical therapies and services related to cardiac rhythm disorders…View ↗
Yes. It kept 13 cents of every revenue dollar as net income in FY2026 and turned 15 cents into free cash flow.
8-K, filed Sep 1, 2026
The company today raised its FY27 organic revenue growth and EPS guidance. The company raised its FY27 organic revenue growth guidance to…View ↗
Diabetes business separation
The earlier report listed Diabetes as an operating and reportable segment. The latest says the Diabetes Business completed an initial public offering and is no longer considered a reportable segment.
10-K for FY2023, filed Jun 22, 2023 10-K for FY2026, filed Jun 18, 2026We have four operating and reportable segments that primarily develop, manufacture, distribute, and sell device-based medical therapies and…View ↗
We have three reportable segments that primarily develop, manufacture, distribute, and sell device-based medical therapies and services…View ↗
Loading...